Neuberger Berman Group LLC Qiagen N.V. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Nov 14, 2024	BUY	$35.55 - $43.57 $50.8 Million - $62.2 Million	1,428,008 New	1,428,008 $62 Million
Q4 2023 Feb 09, 2024	SELL	$35.55 - $43.57 $748,825 - $917,758	-21,064 Reduced 1.45%	1,428,008 $62 Million
Q3 2023 Nov 14, 2023	SELL	$39.13 - $47.24 $1.86 Million - $2.25 Million	-47,549 Reduced 3.18%	1,449,072 $58.7 Million
Q2 2023 Aug 11, 2023	SELL	$43.93 - $46.76 $2.21 Million - $2.35 Million	-50,289 Reduced 3.25%	1,496,621 $67.4 Million
Q1 2023 May 12, 2023	SELL	$45.29 - $50.76 $4.2 Million - $4.71 Million	-92,716 Reduced 5.65%	1,546,910 $71 Million
Q4 2022 Feb 13, 2023	SELL	$41.91 - $50.48 $18.6 Million - $22.4 Million	-442,932 Reduced 21.27%	1,639,626 $81.8 Million
Q3 2022 Nov 15, 2022	SELL	$40.9 - $50.42 $15.9 Million - $19.6 Million	-388,501 Reduced 15.72%	2,082,558 $86 Million
Q2 2022 Aug 15, 2022	BUY	$42.98 - $49.77 $1.79 Million - $2.07 Million	41,604 Added 1.71%	2,471,059 $117 Million
Q1 2022 May 13, 2022	BUY	$42.23 - $54.3 $26.9 Million - $34.6 Million	637,137 Added 35.55%	2,429,455 $118 Million
Q4 2021 Feb 11, 2022	BUY	$50.62 - $56.47 $23.7 Million - $26.5 Million	469,023 Added 35.44%	1,792,318 $99 Million
Q3 2021 Nov 12, 2021	SELL	$46.55 - $56.83 $2.69 Million - $3.29 Million	-57,856 Reduced 4.19%	1,323,295 $68.1 Million
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $5.27 Million - $6 Million	113,787 Added 8.98%	1,381,151 $66.9 Million
Q1 2021 May 13, 2021	BUY	$46.25 - $56.02 $8.79 Million - $10.6 Million	190,040 Added 17.64%	1,267,364 $61.5 Million
Q4 2020 Feb 10, 2021	BUY	$46.09 - $54.74 $48.8 Million - $58 Million	1,059,266 Added 5865.91%	1,077,324 $56.9 Million
Q3 2020 Nov 12, 2020	SELL	$42.51 - $52.42 $104 Million - $128 Million	-2,438,247 Reduced 99.26%	18,058 $943,000
Q2 2020 Aug 13, 2020	SELL	$39.49 - $44.36 $3.27 Million - $3.67 Million	-82,840 Reduced 3.26%	2,456,305 $105 Million
Q1 2020 May 14, 2020	BUY	$33.17 - $41.6 $4.36 Million - $5.47 Million	131,509 Added 5.46%	2,539,145 $106 Million
Q4 2019 Feb 12, 2020	SELL	$25.41 - $43.1 $1.12 Million - $1.9 Million	-43,978 Reduced 1.79%	2,407,636 $82 Million
Q3 2019 Nov 13, 2019	BUY	$32.73 - $40.81 $32.9 Million - $41 Million	1,003,997 Added 69.36%	2,451,614 $80.8 Million
Q2 2019 Aug 13, 2019	SELL	$35.73 - $41.39 $500,863 - $580,205	-14,018 Reduced 0.96%	1,447,617 $58.7 Million
Q1 2019 May 13, 2019	SELL	$33.78 - $40.68 $427,452 - $514,764	-12,654 Reduced 0.86%	1,461,635 $59.5 Million
Q4 2018 Feb 12, 2019	SELL	$32.65 - $37.95 $378,282 - $439,688	-11,586 Reduced 0.78%	1,474,289 $50.8 Million
Q3 2018 Nov 13, 2018	SELL	$35.99 - $39.39 $634,503 - $694,445	-17,630 Reduced 1.17%	1,485,875 $56.3 Million
Q2 2018 Aug 13, 2018	SELL	$31.23 - $37.47 $270,045 - $324,003	-8,647 Reduced 0.57%	1,503,505 $54.4 Million
Q1 2018 May 08, 2018	BUY	$31.01 - $34.72 $5.57 Million - $6.24 Million	179,581 Added 13.48%	1,512,152 $48.9 Million
Q4 2017 Feb 14, 2018	BUY	$30.68 - $35.37 $210,158 - $242,284	6,850 Added 0.52%	1,332,571 $41.2 Million
Q3 2017 Nov 15, 2017	BUY	$31.02 - $32.94 $41.1 Million - $43.7 Million	1,325,721	1,325,721 $41.8 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$176 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$38 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

796K
Shares

$32.5 Million
3.21% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.26 Million
0.01% of portfolio
Bdl Capital Management Paris, I0

88.8K
Shares

$3.62 Million
3.33% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.29B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account